INDICAID™妥析™新冠病毒快速抗原檢測試劑盒 INDICAID™妥析™
INDICAID Rapid Antigen Test HK (25-kit product content) is a HK government designated brand and provides results in 20 minutes
INDICAID™妥析™新冠病毒快速抗原檢測試劑盒 INDICAID™妥析™
INDICAID Rapid Antigen Test HK (25-kit product content) is a HK government designated brand and provides results in 20 minutes

INDICAID™ COVID-19 Rapid Antigen Test Kit

Testing method: Self-test
$500.00 HKD
Specifications: 25-kit (Expiry by Dec 2025)
25-kit (Expiry by Dec 2025)
【推廣優惠】5折半價優惠, 平均一件$10。
優惠期至2025年9月31日
Share
注意事項

1可檢測新冠變種病毒
- 可檢測到的變種病毒包括 Alpha (B.1.1.7)、Beta (B.1.351)、Gamma (P.1)、Delta (B.1.617.2)、Delta Plus (AY.1 and AY.2) 和多種 Omicron 變異株如 BA.2 和 XBB

2 美國 FDA 授權
- INDICAID®️妥析®️新冠病毒快速抗原檢測試劑盒於2021年7月獲取美國 FDA 緊急使用授權

訂單及送貨
  1. Enjoy free delivery service when you spend $300 or more per order; standard delivery fee is $40 for orders below $300
  2. 購物後一般於2個工作天內送貨 (偏遠地區除外)，具體時間以順豐 App為準 (請下載順豐 App以獲取最新的派遞狀態)。特殊情況如長假或惡劣天氣後，派遞可能會順延多１至２個工作天
  3. Express Delivery available with an additional $200 delivery fee
  • Same day delivery for orders before 3pm from Monday to Friday
  • Delivery on the next working day for orders after 3pm from Monday to Friday
  • Delivery on the next working day for orders after Friday 3pm, during weekends and public holidays
  • Express delivery service excludes SF lockers, remote areas and outlying islands
  1. Sales and delivery only available in HK

INDICAID妥析新冠病毒快速抗原測試是香港政府指定快速測試品牌，並已取得美國FDA緊急使用授權及歐盟CE認證，檢測包括Delta及Omicron變種病毒。  INDICAID妥析新型冠狀病毒 (Covid-19) 快測讓您可隨時隨地自助測試新冠病毒。

INDICAID®COVID-19 Rapid Antigen Test is easy to use,

allowing you to self-test anytime and anywhere to detect the presence of the SARS‐CoV‐2 virus.

Features

spec icon
HK brand with

locally developed technology

spec icon
HK Government-designated

rapid antigen test for hospitals and nursing homes

spec icon
Accurate result in

20 minutes

spec icon
Able to detect coronavirus variants

(incl. Delta & Omicron)1

spec icon
U.S. FDA EUA2

(incl. asymptomatic patients)

EU CE Certification

spec icon
Clinically validated with 96% sensitivity &

99% specificity

Suitable for

spec icon
Close contact with COVID-19 patients / developed COVID-19 symptoms
spec icon
Exposed to high occupational risk
spec icon
Residents in high-risk areas
spec icon
Families with elderly or children

Instruction

  1. Collect anterior nasal swab specimen
  2. Stir the swab into the buffer solution by twisting the swab back and forth 20 times
  3. Drop 3 drops of the buffer solution into the test device
  4. Read the results promptly in 20 minutes (results after 25 minutes should not be used)

Complete Instruction Guide: Download

Remarks
  • Wash your hands thoroughly with soap and water before collecting the specimen
  • Swab at a well-ventilated area
  • Maintain social distance of at least 2 meters while using the kit
  • The test must be performed between 15-30°
  • All components in this test kit are for one-time use only
  • Store at 2-30°C. Do not freeze. Avoid direct sunlight

FAQs

How to interpret the results?
Negative: A line appears in the region (C)
Positive: A line appears in regions (C) and (T)
Invalid Result: No line appears in the region (C)


Positive Result: Please seek medical advice promptly, while your family members and close contacts should also get tested.
Negative Result: Regular testing (at least once every week) is recommended to protect yourself and your family members.

Is the result accurate?
The accuracy of COVID-19 Rapid Antigen Test is measured under two metrics:
  • Sensitivity: Measures the ability to correctly identify positive patient samples. If a test kit has a high sensitivity, it means that the kit has a high positive percentage agreement and a low false negative rate
  • Specificity: Measures the ability to correctly identify negative patient samples. If a test kit has a high specificity, it means that the kit has a high negative percentage agreement and a low false positive rate
INDICAID® Rapid Antigen Test HK's overall sensitivity and specificity is 96% and 99% respectively, and is able to detect the presence of certain COVID-19 variants.
Has INDICAID®️ gone through any clinical validation?
INDICAID® Rapid Antigen Test HK has passed extensive clinical validation. In HK Government’s Community Testing Scheme, INDICAID® has been used as part of the HK dual-track testing scheme along with COVID-19 PCR tests. As of January 2021, after the completion of 22994 clinical tests, it has been shown to reach accuracy comparable to PCR tests. This is the world's largest clinical study for a product of its kind.
查看更多

You may also like

spec icon

COVID-19/FLU A&B
Rapid Antigen Test

Learn more
spec icon

UU Tube

H. Pylori Antigen Test

Learn more